Insulet Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Insulet Corp 公司

Insulet Corporation 是一家醫療設備公司。該公司主要從事爲胰島素依賴型糖尿病患者開發、製造和銷售其持續胰島素輸送系統。Omnipod 系統包括 Omnipod 5 自動胰島素輸送系統 (Omnipod 5)、Omnipod DASH 胰島素管理系統、Omnipod 胰島素管理系統和 Omnipod GO。該公司還爲安進公司生產用於 Neulasta Onpro 套件的膠囊，該套件是安進公司 Neulasta 的輸送系統。Omnipod 平臺提供持續胰島素輸送，可提供胰島素泵治療的各種益處，而無需傳統泵所需的外部管道。小巧、輕便、自粘式一次性無管 Omnipod 設備 (Pod) 可佩戴在多個位置，包括腹部、臀部、上臂後部、大腿上部或下背部，並通過小型柔性管將胰島素輸送到體內。Omnipod 5 包括嵌入在 Pod 中的 AID 算法。

公司簡介

公司代碼PODD

公司名稱Insulet Corp

上市日期May 15, 2007

成立日期2000

CEOMs. Ashley Mcevoy

員工數量3900

證券類型Ordinary Share

年結日May 15

公司地址100 Nagog Park

城市ACTON

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編01720-3440

電話19786007000

網址https://www.omnipod.com

公司代碼PODD

上市日期May 15, 2007

成立日期2000

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

4.46K

--

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

2.79K

--

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.12K

+53.26%

名稱

名稱/職務

職務

持股

持股變動

Dr. Jessica Hopfield, Ph.D.

Independent Director

26.92K

--

Mr. Michael R. Minogue

Independent Director

15.45K

+5.77%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

+53.95%

Mr. Prem Singh

Senior Vice President - Global Operations

5.32K

+50.42%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Controller

5.22K

+17.01%

Ms. Ana Maria Chadwick

Chief Financial Officer, Executive Vice President, Treasurer

4.64K

-70.79%

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

業務USD

名稱

營收

佔比

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

地區USD

名稱

營收

佔比

United States

1.55B

74.73%

All Other

523.40M

25.27%

業務

地區

業務USD

名稱

營收

佔比

U.S.Omnipod

1.51B

72.86%

International Omnipod

523.40M

25.27%

Drug Delivery

38.90M

1.88%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

12.05%

Capital Research Global Investors

10.60%

Fidelity Management & Research Company LLC

10.08%

BlackRock Institutional Trust Company, N.A.

6.05%

State Street Global Advisors (US)

4.24%

Other

56.98%

股東類型

股東統計

佔比

Investment Advisor

55.61%

Investment Advisor/Hedge Fund

35.89%

Hedge Fund

3.60%

Research Firm

2.91%

Pension Fund

1.75%

Sovereign Wealth Fund

1.43%

Bank and Trust

1.36%

Private Equity

0.33%

Individual Investor

0.28%

機構持股

更新時間: 1月20日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

1508

72.93M

103.85%

-4.38M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

2022Q4

1126

71.74M

103.30%

-3.89M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

8.46M

12.05%

+16.65K

+0.20%

Dec 31, 2024

Capital Research Global Investors

7.45M

10.6%

-326.10K

-4.20%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.08M

10.08%

-246.09K

-3.36%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.25M

6.05%

+74.08K

+1.77%

Dec 31, 2024

State Street Global Advisors (US)

2.97M

4.24%

+59.55K

+2.04%

Dec 31, 2024

Baillie Gifford & Co.

2.36M

3.35%

+79.98K

+3.51%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.78M

2.53%

+40.57K

+2.33%

Dec 31, 2024

Fidelity International

1.43M

2.04%

-9.70K

-0.67%

Dec 31, 2024

ClearBridge Investments, LLC

1.41M

2%

-62.73K

-4.27%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

953.02K

1.36%

-911.00

-0.10%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

Langar Global HealthTech ETF

6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

5.13%

Goldman Sachs Future Health Care Equity ETF

4.71%

Global X Telemedicine & Digital Health ETF

4.21%

Fidelity Digital Health ETF

3.91%

Congress SMid Growth ETF

2.6%

Harbor Health Care ETF

2.32%

iShares U.S. Medical Devices ETF

2.03%

First Trust Health Care Alphadex Fund

1.8%

iShares Health Innovation Active ETF

1.76%

Langar Global HealthTech ETF

佔比6.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比5.13%

Goldman Sachs Future Health Care Equity ETF

佔比4.71%

Global X Telemedicine & Digital Health ETF

佔比4.21%

Fidelity Digital Health ETF

佔比3.91%

Congress SMid Growth ETF

佔比2.6%

Harbor Health Care ETF

佔比2.32%

iShares U.S. Medical Devices ETF

佔比2.03%

First Trust Health Care Alphadex Fund

佔比1.8%

iShares Health Innovation Active ETF

佔比1.76%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Insulet Corp

253.820USD

Insulet Corp

253.820

概覽

公司